标题
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
作者
关键词
-
出版物
Emerging Microbes & Infections
Volume 9, Issue 1, Pages 194-206
出版商
Informa UK Limited
发表日期
2020-01-27
DOI
10.1080/22221751.2020.1713707
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
- (2019) Frances H Priddy et al. Lancet HIV
- Improvement of antibody functionality by structure-guided paratope engraftment
- (2019) Qingbo Liu et al. Nature Communications
- Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
- (2019) Chang-Yi Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Trevor A Crowell et al. Lancet HIV
- Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
- (2019) Kim Anthony-Gonda et al. Science Translational Medicine
- Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
- (2019) Eytan Herzig et al. CELL
- Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants
- (2019) Coleen K Cunningham et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
- (2019) Martin R Gaudinski et al. Lancet HIV
- New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment
- (2018) Lucio Gama et al. Annual Review of Medicine
- Therapeutic Efficacy of Vectored PGT121 Gene Delivery in HIV-1-Infected Humanized Mice
- (2018) Alexander Badamchi-Zadeh et al. JOURNAL OF VIROLOGY
- Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions
- (2018) Edurne Rujas et al. JOURNAL OF VIROLOGY
- A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection
- (2018) Rajeev Gautam et al. NATURE MEDICINE
- Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
- (2018) James J. Steinhardt et al. Nature Communications
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
- (2018) Martin R. Gaudinski et al. PLOS MEDICINE
- Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
- (2018) Kshitij Wagh et al. PLoS Pathogens
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression
- (2018) Pilar Mendoza et al. NATURE
- Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
- (2018) Yotam Bar-On et al. NATURE MEDICINE
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
- (2018) Brinda Emu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
- (2018) Erica N. Borducchi et al. NATURE
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Systems serology for evaluation of HIV vaccine trials
- (2017) Margaret E. Ackerman et al. IMMUNOLOGICAL REVIEWS
- Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs
- (2017) Hongru Li et al. JOURNAL OF VIROLOGY
- Early antibody therapy can induce long-lasting immunity to SHIV
- (2017) Yoshiaki Nishimura et al. NATURE
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
- (2017) Ling Xu et al. SCIENCE
- Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection
- (2017) Matthew S. Parsons et al. Science Translational Medicine
- Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail
- (2017) Boris Julg et al. Science Translational Medicine
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
- (2017) Kenneth H. Mayer et al. PLOS MEDICINE
- Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4 + T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy
- (2016) Bingfeng Liu et al. JOURNAL OF VIROLOGY
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
- (2016) Rajeev Gautam et al. NATURE
- Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
- (2016) Ann J Hessell et al. NATURE MEDICINE
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
- (2016) T. Schoofs et al. SCIENCE
- Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
- (2016) C.-L. Lu et al. SCIENCE
- The preexposure prophylaxis revolution; from clinical trials to programmatic implementation
- (2016) Nelly R. Mugo et al. Current Opinion in HIV and AIDS
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
- (2015) J. E. Ledgerwood et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
- (2015) Stylianos Bournazos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization
- (2015) M. Asokan et al. JOURNAL OF VIROLOGY
- Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection
- (2015) Kevin O. Saunders et al. JOURNAL OF VIROLOGY
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent
- (2015) Lucia Reh et al. PLoS Pathogens
- Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
- (2014) Ariel Halper-Stromberg et al. CELL
- Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells
- (2014) M. J. Buzon et al. JOURNAL OF VIROLOGY
- Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
- (2014) Sung-Youl Ko et al. NATURE
- Loss of Infectivity of HIV-1 Particles Produced by Mobile Lymphocytes
- (2014) Maxime Chazal et al. PLoS One
- Neutralisation of HIV-1 cell-cell spread by human and llama antibodies
- (2014) Laura E McCoy et al. Retrovirology
- Unique Features of HIV-1 Spread through T Cell Virological Synapses
- (2014) Raymond A. Alvarez et al. PLoS Pathogens
- Cause-Specific Life Expectancies After 35 Years of Age for Human Immunodeficiency Syndrome-Infected and Human Immunodeficiency Syndrome-Negative Individuals Followed Simultaneously in Long-term Cohort Studies, 1984–2008
- (2013) Nikolas Wada et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
- (2013) Marine Malbec et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies
- (2013) Guang Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High-Multiplicity HIV-1 Infection and Neutralizing Antibody Evasion Mediated by the Macrophage-T Cell Virological Synapse
- (2013) C. J. A. Duncan et al. JOURNAL OF VIROLOGY
- Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
- (2013) Dan H. Barouch et al. NATURE
- Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1–neutralizing activity
- (2013) Ruijiang Song et al. NATURE BIOTECHNOLOGY
- Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues
- (2013) A. P. West et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of enhanced HIV spread through T-cell virological synapses
- (2012) Benjamin M. Dale et al. IMMUNOLOGICAL REVIEWS
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
- (2012) Florian Klein et al. NATURE
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
- (2012) B. Moldt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
- (2012) Irene A. Abela et al. PLoS Pathogens
- Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection
- (2011) A. Del Portillo et al. JOURNAL OF VIROLOGY
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
- (2011) Alex Sigal et al. NATURE
- Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
- (2011) R. Diskin et al. SCIENCE
- The direct passage of animal viruses between cells
- (2011) Quentin J Sattentau Current Opinion in Virology
- Virological Synapse-Mediated Spread of Human Immunodeficiency Virus Type 1 between T Cells Is Sensitive to Entry Inhibition
- (2010) N. Martin et al. JOURNAL OF VIROLOGY
- Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors
- (2010) Dmitriy Mazurov et al. PLoS Pathogens
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells
- (2008) Marta Massanella et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search